Sort
10,766 grants matching “checkpoint inhibitor”
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$12,350James R. Heath · Institute For Systems Biology · U54 · FY2024 · CA
Project 4: Immunovirotherapy
$12,136Richard G Vile · Mayo Clinic Rochester · P50 · FY2019 · CA
Project 4: Immunovirotherapy
$12,136Richard G Vile · Mayo Clinic Rochester · P50 · FY2019 · CA
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes
$11,997Marianne Berwick · University Of New Mexico Health Scis Ctr · P01 · FY2020 · CA
Cancer Immunology Research Program
$11,905Lieping Chen · Yale University · P30 · FY2018 · CA
Cancer Immunology Research Program
$11,904Lieping Chen · Yale University · P30 · FY2018 · CA
Signal Transduction Research Program
$11,904Daniel Peter Petrylak · Yale University · P30 · FY2019 · CA
Cancer Immunology Research Program
$11,904Lieping Chen · Yale University · P30 · FY2019 · CA
Signal Transduction Research Program
$11,904Daniel Peter Petrylak · Yale University · P30 · FY2018 · CA
Signal Transduction Research Program
$11,904Daniel Peter Petrylak · Yale University · P30 · FY2018 · CA
HPV AND ANTIGEN PRESENTING CELLS
$11,860W Martin Kast · University Of Southern California · R01 · FY2019 · CA
Investigating the role of EphA2 receptor tyrosine kinase in anti-tumor immunity mediated through programmed cell death ligand 2 (PD-L2) in non-small cell lung cancer (NSCLC)
$11,778Eileen Shiuan · Vanderbilt University · F30 · FY2020 · CA
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$11,557Jens Marc Titze · Vanderbilt University Medical Center · U54 · FY2018 · CA
Dissecting host-pathogen interactions through the lens of genomics
$11,517Majid Kazemian · Purdue University · R35 · FY2022 · GM
Program 4: Leukemia
$11,431Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Program 30: Neuro-Oncology
$11,430Charles Stiles · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Elucidating time-dependent mechanisms of genetic and epigenetic reprogramming in single cancer cells
$11,375Raul Rabadan · Columbia University Health Sciences · U54 · FY2019 · CA
Function of the ATR-ATRIP complex
$11,354David K Cortez · Vanderbilt University · R01 · FY2015 · CA
Dissecting Early Tumor Evolution to Uncover Mechanisms of Tumor Initiation and Drug Resistance
$11,333Matthew James Ryan · University Of California, San Francisco · F31 · FY2024 · CA
Lymphoma & Leukemia Research Program (Project-007)
$11,296Ronald Levy · Stanford University · P30 · FY2018 · CA
Dissecting host-pathogen interactions through the lens of genomics
$10,984Majid Kazemian · Purdue University · R35 · FY2023 · GM
Regulation of translation through the human translation initiation factor eIF5B
$10,778Assen G Marintchev · Harvard Medical School · K01 · FY2008 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$10,564Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA
Defining the roles of ERK MAPK in driving KRAS-mutant pancreatic cancer growth.
$10,380Jennifer E Klomp · Univ Of North Carolina Chapel Hill · F32 · FY2020 · CA
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$10,180Jens Marc Titze · Vanderbilt University Medical Center · U54 · FY2019 · CA